Search Results - "Tawe, Leabaneng"
-
1
High-risk human papillomavirus diversity among indigenous women of western Botswana with normal cervical cytology and dysplasia
Published in BMC infectious diseases (15-10-2024)“…Cervical cancer remains a public health problem despite heavy global investment in health systems especially in low-and-middle-income countries (LMIC)…”
Get full text
Journal Article -
2
Genetic diversity in L1 ORF of human papillomavirus in women with cervical cancer with and without human immunodeficiency virus in Botswana and Kenya
Published in BMC infectious diseases (27-01-2022)“…The variation of human papillomavirus (HPV) genotypes shapes the risks of cervical cancer and these variations are not well defined in Africa. Nucleotide…”
Get full text
Journal Article -
3
Promoter Hypermethylation Analysis of Host Genes in Cervical Cancer Patients With and Without Human Immunodeficiency Virus in Botswana
Published in Frontiers in oncology (26-02-2021)“…Epidemics of human immunodeficiency virus (HIV) and cervical cancer are interconnected. DNA hypermethylation of host genes' promoter in cervical lesions has…”
Get full text
Journal Article -
4
Human cytochrome P450 2B6 genetic variability in Botswana: a case of haplotype diversity and convergent phenotypes
Published in Scientific reports (20-03-2018)“…Identification of inter-individual variability for drug metabolism through cytochrome P450 2B6 (CYP2B6) enzyme is important for understanding the differences…”
Get full text
Journal Article -
5
Molecular Surveillance of Plasmodium falciparum Drug Resistance Markers in Clinical Samples from Botswana
Published in The American journal of tropical medicine and hygiene (01-01-2018)“…Drug-resistant is a major threat to global malaria control and elimination efforts. In Botswana, a southern African country approaching malaria elimination,…”
Get full text
Journal Article -
6
Cervical cancer screening in HIV-endemic countries: An urgent call for guideline change
Published in Cancer treatment and research communications (2023)“…•In Botswana, median age of cervical cancer diagnosis for women living with HIV was 47.9.•Among women living without HIV, median age at cervical cancer…”
Get full text
Journal Article -
7
No Difference in the Prevalence of HIV-1 gag Cytotoxic T-Lymphocyte-Associated Escape Mutations in Viral Sequences from Early and Late Parts of the HIV-1 Subtype C Pandemic in Botswana
Published in Vaccines (Basel) (19-05-2023)“…HIV is known to accumulate escape mutations in the gene in response to the immune response from cytotoxic T lymphocytes (CTLs). These mutations can occur…”
Get full text
Journal Article -
8
Comparison of the AmpFire® Multiplex HPV Assay to the Xpert® HPV Assay for detection of human papillomavirus and cervical disease in women with human immunodeficiency virus: a pragmatic performance evaluation
Published in Infectious agents and cancer (10-05-2023)“…Low- and middle-income countries (LMICs) account for nearly 85% of the global cervical cancer burden, yet have the least access to high-performance screening…”
Get full text
Journal Article -
9
Molecular detection of human papillomavirus (HPV) in highly fragmented DNA from cervical cancer biopsies using double-nested PCR
Published in MethodsX (01-01-2018)“…[Display omitted] Archived Formalin-Fixed Paraffin-Embedded (FFPE) tissue specimens can be a valuable source of human papillomavirus (HPV) nucleic acids for…”
Get full text
Journal Article -
10
Cervical human papillomavirus genotypes in a high HIV setting: A scoping review of a decade of human papillomavirus epidemiological research in Botswana
Published in Frontiers in medicine (24-11-2022)“…Cervical cancer burden is still high in low- and middle-income countries, including Botswana. Persistent human papillomavirus (HPV) infection is the leading…”
Get full text
Journal Article -
11
Cytochrome P450 2C82 allele in Botswana: Human genetic diversity and public health implications
Published in Acta tropica (01-05-2016)“…We studied the frequency of CYP2C8*2 allele in two ethnic group from Botswana. In the San the rate of poor metabolisers of antimalarial drugs is higher than in…”
Get full text
Journal Article -
12
-
13
Past and current biological factors affecting malaria in the low transmission setting of Botswana: A review
Published in Infection, genetics and evolution (01-11-2020)“…Malaria continues to be one of the top infectious agents contributing to morbidity and mortality in sub-Saharan Africa. Annually, Botswana accounts only for a…”
Get full text
Journal Article -
14
Human papillomavirus genotypes in women with invasive cervical cancer with and without human immunodeficiency virus infection in Botswana
Published in International journal of cancer (15-03-2020)“…Cervical cancer remains a significant cause of morbidity and mortality in women worldwide and is the leading cause of cancer‐related death in Botswana. It is…”
Get full text
Journal Article -
15
Evaluation of a Novel Semiquantitative Cryptococcal Antigen Lateral Flow Assay in Patients with Advanced HIV Disease
Published in Journal of clinical microbiology (24-08-2020)“…Higher cryptococcal antigen (CrAg) titers are strongly associated with mortality risk in individuals with HIV-associated cryptococcal disease. Rapid tests to…”
Get full text
Journal Article -
16
The role of CYP2B6 516G>T polymorphism on efavirenz/nevirapine toxicity. Implications on treatment outcomes : Lessons from Botswana
Published in Medicine (Baltimore) (29-04-2022)“…The two non-nucleoside reverse transcriptase inhibitors (NNRTIs), efavirenz (EFV) and nevirapine (NVP), are currently the core antiretroviral drugs for…”
Get full text
Journal Article -
17
Triage of HPV positivity in a high HIV prevalence setting: A prospective cohort study comparing visual triage methods and HPV genotype restriction in Botswana
Published in International journal of gynecology and obstetrics (01-05-2024)“…Objective Guidelines for effective triage following positive primary high‐risk human papillomavirus (HPV) screening in low‐ and middle‐income countries with…”
Get full text
Journal Article -
18
The role of CYP2B6 516G>T polymorphism on efavirenz/nevirapine toxicity. Implications on treatment outcomes
Published in Medicine (Baltimore) (01-04-2022)“…The two non-nucleoside reverse transcriptase inhibitors (NNRTIs), efavirenz (EFV) and nevirapine (NVP), are currently the core antiretroviral drugs for…”
Get full text
Journal Article -
19
Diagnostic Accuracy of the Biosynex CryptoPS Cryptococcal Antigen Semiquantitative Lateral Flow Assay in Patients with Advanced HIV Disease
Published in Journal of clinical microbiology (17-12-2020)“…High cryptococcal antigen (CrAg) titers in blood are associated with subclinical meningitis and mortality in CrAg-positive individuals with advanced HIV…”
Get full text
Journal Article -
20
Outcomes of Reflex Cryptococcal Antigen (CrAg) Screening in Human Immunodeficiency Virus (HIV)-Positive Patients With CD4 Counts of 100-200 Cells/µL in Botswana
Published in Clinical infectious diseases (04-05-2021)“…Increasing the CD4-count threshold for cryptococcal antigen (CrAg) screening from ≤100 to ≤200 cells/µL resulted in a 3-fold increase in numbers screened…”
Get full text
Journal Article